| Filed On | Filing |
|---|---|
| 27 Oct 2026 |
8-K: Other Events
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: |
| 08 Oct 2026 |
8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities +1 more
This SECURITIES PURCHASE AGREEMENT (this “Agreement”) is dated as of October 7, 2026, by and among Atrium Therapeutics, Inc., a Delaware corporation (the “Company”), and each of the entities listed on Exhibit A attached to this Agreement... |
| 13 Aug 2026 | 8-K: Results of Operations and Financial Condition |
| 14 Jul 2026 | 8-K: Other Events |
| 14 May 2026 | 8-K: Results of Operations and Financial Condition |
| 27 Feb 2026 | 8-K: Entry into a Material Definitive Agreement; Changes in Control of Registrant +1 more |
| 26 Feb 2026 | 8-K: Regulation FD Disclosure |
Loading...
